Document is current
Any future updates will be listed below
-
Authors
Kim, Paul D. https://orcid.org/0000-0002-1544-2309
Raiszadeh, Ramin https://orcid.org/0000-0001-9943-106X
Bomback, David A.
Kramer, David L.
Moghimi, Michael
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct03425682 at ClinicalTrials.govDocuments that mention this clinical trial
12-Month clinical and radiographic outcomes of ViBone viable bone matrix in patients undergoing cervical and lumbar spinal fusion surgery
https://doi.org/10.1186/s13018-023-03686-9
-
Funding
Funding for this research was provided by:
Aziyo Biologics, Inc
- License Information
-
More Information
Article History
Received: 11 February 2022
Accepted: 7 March 2023
First Online: 25 March 2023
Declarations
:
: This study received initial approval from WCG IRB on 12/1/2017, and approval at each local facility followed thereafter. An IRB-approved informed consent form was obtained from all patients included in the study.
: All study patients consented to the use of their PHI according to all applicable health information privacy regulations in this study.
: One of the authors (PDK) also receives grants/research funds from Allosource; consulting fees from Globus Medical, Spinal Elements, SurgAlign, Aziyo Biologics, and Allosource; and royalties from Globus, Spinal Elements, and SurgAlign. The other authors (RR, DAB, DLK, MM) declare they have no other competing interests.
